Safety and Efficacy of Dexmedetomidine in Painless Colonoscopy

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Colonoscopy
Interventions
DRUG

Dexmedetomidine group

In the dexmedetomidine group, dexmedetomidine was infusion intravenously with a loading dose of 0.5 μg kg-1 for 10 min, then infusion at 0.3 μg kg-1 h-1 according to the ideal body weight of the patient until the end of colonoscopy. If Ramsay sedation scale score reached 3, colonoscope was inserted. During the whole process, maintenance Ramsay score of 3 to 4. Propofol 10 mg was administrated as the rescue dose if body movement occurred during colonoscopy. In the propofol group, propofol was administrated 1 mg kg-1 intravenously, then titrated given by 0.5 mg kg-1 until Ramsay score reached 3. During the whole process, propofol was given intermittently to maintain Ramsay score 3 to 4. If body movement happened, propofol 10mg was administrated every time.

Trial Locations (1)

610041

West China Hospital, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT03892928 - Safety and Efficacy of Dexmedetomidine in Painless Colonoscopy | Biotech Hunter | Biotech Hunter